A Safety and Tolerability Study of INCB053914 in Combination With INCB050465 in Diffuse Large B-Cell Lymphoma
Clinical trial NCT03688152 · COMPLETED
Trial details
- NCT number
- NCT03688152
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-03
- Primary completion
- 2020-09-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.